RenovoRx (RNXT) Earnings Date & Reports

RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical needs with a goal to improve therapeutic outcomes for cancer patients undergoing treatment... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

RNXT is expected to report earnings to rise 16.67% to -7 cents per share on November 16

Q3'26

Est.

$-0.07

Q2'26

Beat

by $0.02

Q1'26

Missed

by $0.01

Q4'25

Est.

$-0.08

Q3'25

Est.

$-0.08

The last earnings report on August 12 showed earnings per share of -5 cents, beating the estimate of -7 cents. With 612.75K shares outstanding, the current market capitalization sits at 74.91M.

View a ticker or compare two or three

RNXT

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

View AI-Driven Trading for RNXT